In last trading session, Revelation Biosciences Inc (NASDAQ:REVB) saw 0.44 million shares changing hands with its beta currently measuring 0.23. Company’s recent per share price level of $0.53 trading at -$0.05 or -8.83% at ring of the bell on the day assigns it a market valuation of $4.42M. That closing price of REVB’s stock is at a discount of -4666.04% from its 52-week high price of $25.26 and is indicating a premium of 47.17% from its 52-week low price of $0.28. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 13.07 million shares which gives us an average trading volume of 3.07 million if we extend that period to 3-months.
For Revelation Biosciences Inc (REVB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.43 in the current quarter.
Revelation Biosciences Inc (NASDAQ:REVB) trade information
Upright in the red during last session for losing -8.83%, in the last five days REVB remained trading in the red while hitting it’s week-highest on Monday, 01/06/25 when the stock touched $0.53 price level, adding 24.29% to its value on the day. Revelation Biosciences Inc’s shares saw a change of 14.71% in year-to-date performance and have moved -19.51% in past 5-day. Revelation Biosciences Inc (NASDAQ:REVB) showed a performance of 17.51% in past 30-days. Number of shares sold short was 43682.0 shares which calculate 0.03 days to cover the short interests.
Revelation Biosciences Inc (REVB) estimates and forecasts
Statistics highlight that Revelation Biosciences Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -70.62% of value to its shares in past 6 months, showing an annual growth rate of 79.76% while that of industry is 16.50. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
Revelation Biosciences Inc (NASDAQ:REVB)’s Major holders
Insiders are in possession of 0.03% of company’s total shares while institution are holding 11.37 percent of that, with stock having share float percentage of 11.37%. Investors also watch the number of corporate investors in a company very closely, which is 11.37% institutions for Revelation Biosciences Inc that are currently holding shares of the company.
On the other hand, Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of Nov 30, 2024 , the former fund manager was holding 8.02 shares of worth $4242.0 or 0.10% of the total outstanding shares. The later fund manager was in possession of 2.94 shares on Nov 30, 2024 , making its stake of worth around $1555.0 in the company or a holder of 0.04% of company’s stock.
